Kerala Ayurveda Ltd's board approved issuance of 4,000 Series 'A' unlisted, secured, redeemable NCDs aggregating ₹40 crores via private placement on March 25, 2026.
NCDs carry 12% p.a. interest on reducing balance, with a 24-month moratorium followed by 32 quarterly principal instalments, over a tenure of up to 10 years.
Security offered is a first charge on industrial property (factory land, building, and plant & machinery) at Nedumbassery, Ernakulam, Kerala.
The borrowing is within shareholder-approved limits under Section 180(1)(c) of the Companies Act, 2013, as approved on August 22, 2025.